The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro
Malin Wickström(Karolinska University Hospital), Joachim Gullbo(Theradex Oncology (United States)), Peter Nygren(Uppsala University), Henrik Lindman(Uppsala University), Caroline Haglund(Uppsala University Hospital), Rolf Larsson(Uppsala University)
Cited by 40
Related Papers
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
|Frontiers in Molecular Neuroscience|2019|284
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [<sup>68</sup>Ga]ABY-025 Affibody PET/CT
|Theranostics|2015|269
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule
|Journal of Nuclear Medicine|2014|260